Works matching IS 14611457 AND DT 2022 AND VI 25 AND IP 9

Results: 8

5-HT5A Receptor Antagonist ASP5736 Ameliorates Several Abnormal Behaviors in an Fmr1-Targeted Transgenic Male Rat Model of Fragile X Syndrome.

Published in:

International Journal of Neuropsychopharmacology, 2022, v. 25, n. 9, p. 786, doi. 10.1093/ijnp/pyac041

By:

Yamazaki, Mayako;
Arai, Takatomo;
Yarimizu, Junko;
Matsumoto, Mitsuyuki

Publication type:

Article

Basolateral Amygdala SIRT1/PGC-1α Mitochondrial Biogenesis Pathway Mediates Morphine Withdrawal-Associated Anxiety in Mice.

Published in:

International Journal of Neuropsychopharmacology, 2022, v. 25, n. 9, p. 774, doi. 10.1093/ijnp/pyac040

By:

Yin, Fangyuan;
Zhang, Jinyu;
Liu, Yige;
Zhai, Yifang;
Luo, Danlei;
Yan, Xinyue;
Feng, Yue;
Lai, Jianghua;
Zheng, Haibo;
Wei, Shuguang;
Wang, Yunpeng

Publication type:

Article

Alpha-2 Adrenoreceptor Antagonist Yohimbine Potentiates Consolidation of Conditioned Fear.

Published in:

International Journal of Neuropsychopharmacology, 2022, v. 25, n. 9, p. 759, doi. 10.1093/ijnp/pyac038

By:

Sperl, Matthias F J;
Panitz, Christian;
Skoluda, Nadine;
Nater, Urs M;
Pizzagalli, Diego A;
Hermann, Christiane;
Mueller, Erik M

Publication type:

Article

Impulse Control Disorders by Dopamine Partial Agonists: A Pharmacovigilance-Pharmacodynamic Assessment Through the FDA Adverse Event Reporting System.

Published in:

International Journal of Neuropsychopharmacology, 2022, v. 25, n. 9, p. 727, doi. 10.1093/ijnp/pyac031

By:

Fusaroli, Michele;
Raschi, Emanuel;
Giunchi, Valentina;
Menchetti, Marco;
Giorgini, Roberto Rimondini;
Ponti, Fabrizio De;
Poluzzi, Elisabetta

Publication type:

Article

Enhanced Taste Recognition Following Subacute Treatment With The Dopamine D2/D3 Receptor Agonist Pramipexole in Healthy Volunteers.

Published in:

International Journal of Neuropsychopharmacology, 2022, v. 25, n. 9, p. 720, doi. 10.1093/ijnp/pyac030

By:

Kaltenboeck, Alexander;
Halahakoon, Don Chamith;
Harmer, Catherine J;
Cowen, Philip;
Browning, Michael

Publication type:

Article

Shared and Unique Effects of Long-Term Administration of Methylphenidate and Atomoxetine on Degree Centrality in Medication-Naïve Children With Attention-Deficit/Hyperactive Disorder.

Published in:

International Journal of Neuropsychopharmacology, 2022, v. 25, n. 9, p. 709, doi. 10.1093/ijnp/pyac028

By:

Fu, Zhao;
Yuan, Jing;
Pei, Xuyao;
Zhang, Kangfuxi;
Xu, Chenyang;
Hu, Na;
Xie, Rao;
Zhao, Yilu;
Wang, Yufeng;
Yang, Li;
Cao, Qingjiu

Publication type:

Article

Polymorphisms in Schizophrenia-Related Genes Are Potential Predictors of Antipsychotic Treatment Resistance and Refractoriness.

Published in:

International Journal of Neuropsychopharmacology, 2022, v. 25, n. 9, p. 701, doi. 10.1093/ijnp/pyac025

By:

Zazueta, Alejandra;
Castillo, Tito;
Cavieres, Álvaro;
González, René;
Abarca, Maximiliano;
Nieto, Rodrigo R;
Deneken, Javier;
Araneda, Cristian;
Moya, Pablo R;
Bustamante, M Leonor

Publication type:

Article

Guidelines for Discontinuation of Antipsychotics in Patients Who Recover From First-Episode Schizophrenia Spectrum Disorders: Derived From the Aggregated Opinions of Asian Network of Early Psychosis Experts and Literature Review.

Published in:

International Journal of Neuropsychopharmacology, 2022, v. 25, n. 9, p. 737, doi. 10.1093/ijnp/pyac002

By:

Group, Asian Network of Early Psychosis Writing

Publication type:

Article